Ig VENA 100 ml vial ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
63Idiopathic thrombocytopenic purpura1

63. Idiopathic thrombocytopenic purpura


Clinical trials : 363 Drugs : 212 - (DrugBank : 43) / Drug target genes : 47 - Drug target pathways : 138
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2013-000961-36-IT
(EUCTR)
22/11/201321/08/2013See the full titleTolerability and safety evaluation of the administration of Ig VENA at high infusion rates. Open label phase III study. - Ig VENA Infusion Speed Patients affected by primary or secondary immunodeficiency (ID) or patients affected by Primary Immune Thrombocytopenia (ITP);Therapeutic area: Diseases [C] - Immune System Diseases [C20]Trade Name: Ig VENA 100 ml vial
Product Name: Ig VENA
Kedrion SpANULLNot RecruitingFemale: yes
Male: yes
35Phase 3Italy